An institutional trader has placed a massive $4M call sweep on Advanced Micro Devices (NASDAQ: AMD), signaling aggressive positioning ahead of the company’s highly anticipated Q1 earnings report. The order targets the $355 strike expiring on May 29, 2026, indicating strong conviction that the semiconductor giant’s current rally has further room to run.

The transaction was executed as an “Auto Opening Unusual Sweep,” with 1,395 contracts purchased at the ask price of $28.40 per contract. With AMD stock trading at $357.24 at the time of execution, these calls are already slightly in-the-money. This aggressive near-term expiration strategy—giving the trade less than a month to play out—suggests the buyer expects an immediate catalyst, likely tied to the upcoming earnings release and forward guidance.
Volume and Open Interest Data
A closer look at the contract data reveals a significant imbalance between volume and existing open interest, confirming this as a new, aggressive position rather than the closing of an existing trade.

The daily volume for the 355C 05/29/2026 contract spiked to 1,563 contracts on May 1, completely dwarfing the prior open interest of just 169 contracts. This extreme volume-to-OI ratio is a classic hallmark of institutional accumulation. Furthermore, the contract price has surged from $13.62 just three days prior to $28.39, reflecting rapidly increasing demand and implied volatility (currently at 67.59%) as traders position themselves for upcoming catalysts.
What’s Happening with AMD
Advanced Micro Devices has been on a historic tear, with the stock surging more than 59% in April alone and gaining over 248% over the past 12 months. The broader semiconductor sector continues to see massive capital inflows, as evidenced by recent aggressive options flow in TSM and other key players.
The immediate focus for Wall Street is AMD’s upcoming Q1 2026 earnings report. Analysts are projecting earnings per share in the $1.28 to $1.30 range on revenues of approximately $9.88 billion. However, the true driver of the stock’s recent momentum is the company’s rapidly expanding footprint in the artificial intelligence accelerator market with its Instinct MI-series GPUs, challenging Nvidia’s dominance in the data center space.
About Advanced Micro Devices (AMD)
Advanced Micro Devices, Inc. operates as a global semiconductor company. Its products include x86 microprocessors as an accelerated processing unit, chipsets, discrete and integrated graphics processing units (GPUs), data center and professional GPUs, and development services. The company’s EPYC server processors and Ryzen desktop/mobile processors have consistently gained market share, while its recent focus has heavily pivoted toward AI infrastructure.
This $4M short-term sweep aligns perfectly with longer-term bullish sentiment we’ve observed recently, including massive LEAPS positioning targeting 2027. Institutions are clearly betting that AMD’s fundamental growth story is far from over.
Analyst Ratings
Wall Street remains overwhelmingly bullish on AMD, with TipRanks reporting a strong consensus of 19 Buy ratings and zero Sell ratings over the past three months. Several major firms have recently upgraded their price targets in anticipation of strong Q1 results and forward guidance.
| Analyst Firm | Rating | Price Target |
|---|---|---|
| UBS | खरीदना | $455 |
| Susquehanna | खरीदना | $380 |
| DA Davidson | खरीदना | $375 |
| Wells Fargo | Overweight | $345 |
| RBC Capital Markets | Outperform | $325 |
UBS recently set a new Street-high price target of $455, citing strong demand for AI accelerators. With the stock currently trading near $357, these targets suggest analysts see significant upside potential, aligning with the aggressive options flow activity observed today.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Options trading involves significant risk and is not suitable for all investors. Always conduct your own due diligence or consult with a licensed financial advisor before making any investment decisions.


